Pacira BioSciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.About PCRX
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.
PCRX Key Statistics
Stock Snapshot
With a market cap of 1.14B, Pacira BioSciences(PCRX) trades at $26.51. The stock has a price-to-earnings ratio of 59.43.
On 2025-12-29, Pacira BioSciences(PCRX) stock moved within a range of $26.01 to $26.63. With shares now at $26.51, the stock is trading +1.9% above its intraday low and -0.5% below the session's peak.
Trading volume for Pacira BioSciences(PCRX) stock has reached 424.24K, versus its average volume of 981.99K.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
Over the past 52 weeks, Pacira BioSciences(PCRX) stock has traded between a high of $27.64 and a low of $18.17.
PCRX News
In December 2025, Pacira BioSciences announced it had joined the European Innovative Health Initiative-funded PROBE Consortium, a global public-private effort u...
Pacira (PCRX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and...